The Impact of Additive PICOs in a European Joint Clinical Health Technology Assessment.

van Engen, Anke; Krüger, Robert; Parnaby, Adam; Rotaru, Mihai; Ryan, James; Samaha, Dima; Tzelis, Dimitrios

van Engen, Anke; Krüger, Robert; Parnaby, Adam; Rotaru, Mihai; Ryan, James; Samaha, Dima; Tzelis, Dimitrios.

Affiliation

van Engen A; Real World Solutions, IQVIA, Netherlands, Amsterdam. Electronic address: anke.vanengen@iqvia.com.
Krüger R; Real World Solutions, IQVIA, South Africa, Pretoria.
Parnaby A; International Policy & Government Affairs, Bristol-Myers Squibb, Belgium, Brussels.
Rotaru M; Director Market Access, European Federation of Pharmaceutical Industries and Associations, Belgium, Brussels.
Ryan J; Oncology Market Access and Pricing, AstraZeneca Ltd., United Kingdom, Cambridge.
Samaha D; Real World Solutions, IQVIA, France, Courbevoie.
Tzelis D; Real World Solutions, IQVIA, United Kingdom, London.

Value Health ; 2024 Aug 09.

Article de En | MEDLINE | ID: mdl-39128703

Mots clés

PICOs; access to medicines; evidence-based decision making; health technology assessment; stakeholders

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Value Health Sujet du journal: FARMACOLOGIA Année: 2024 Type de document: Article Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google